SWM
PRME icon

Shelton Wealth Management’s Prime Medicine PRME Stock Holding History

Shelton Wealth Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70.5K Sell
19,105
-961
-5% -$3.19K 0.03% 139
2026
Q1 		$69.8K Hold
20,066
– – 0.03% 134
2025
Q4 		$69.6K Buy
20,066
+2,734
+16% +$12.2K 0.03% 150
2025
Q3 		$96K Buy
+17,332
New +$70.4K 0.04% 139

Other funds holding PRME

Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Shelton Wealth Management's PRME Position: Q2 2026 in Review

Shelton Wealth Management reduced its Prime Medicine (PRME) stake by 4.8% in Q2 2026, selling an estimated $3.19K and leaving 19,105 shares worth $70.5K. The position accounts for 0.03% of the portfolio, ranked #139.

Shelton Wealth Management first reported a position in PRME in Q3 2025 and has held it in 4 quarters since. The position peaked at $96K in Q3 2025. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Shelton Wealth Management held 19,105 shares of Prime Medicine worth $70.5K as of Q2 2026.
  • Shelton Wealth Management sold 961 Prime Medicine shares in Q2 2026, an estimated $3.19K.
  • Prime Medicine made up 0.03% of Shelton Wealth Management's portfolio in Q2 2026, its #139 holding.
  • Shelton Wealth Management first reported a position in Prime Medicine in Q3 2025 and has held it in 4 quarters since.
  • Shelton Wealth Management's Prime Medicine position peaked at $96K in Q3 2025.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Shelton Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.